Current and Future Clinical Applications of Bone Morphogenetic Proteins in Orthopaedic Trauma Surgery

Overview

Journal Int Orthop

Specialty Orthopedics

Date 2007 Aug 2

PMID 17668207

Citations 91

Authors

Gavin B Bishop

Thomas A Einhorn

Affiliations

Soon will be listed here.

Abstract

Forty years after the discovery by Marshal R. Urist of a substance in bone matrix that has inductive properties for the development of bone and cartilage, there are now 15 individual human bone morphogenetic proteins (BMPs) that possess varying degrees of inductive activities. Two of these, BMP-2 and BMP-7, have become the subject of extensive research aimed at developing therapeutic strategies for the restoration and treatment of skeletal conditions. This has led to three different therapeutic preparations, each for a distinct clinical application. Non-union, open tibial fractures and spinal fusions are the three conditions for which there is clinical approval for use of BMPs. This article reviews the evidence supporting the therapeutic applications of BMPs as they are presently available and suggests future applications based on current research. Among the future directions discussed are percutaneous injections, protein carriers, advances in gene transfer technology and the use of BMPs to engineer the regeneration of skeletal parts.

Citing Articles

Use of osteogenic bone matrix in patients with traumatic long bone defects: An open label, single center study.

Murdoch M, Wittstock C, Psaras G, Widgerow A, Lukhele M, Ramokgopa M J Orthop. 2024; 60:159-166.

PMID: 39678257 PMC: 11635017. DOI: 10.1016/j.jor.2024.08.018.

Exosomal mRNAs for Angiogenic-Osteogenic Coupled Bone Repair.

Ma Y, Sun L, Zhang J, Chiang C, Pan J, Wang X Adv Sci (Weinh). 2023; 10(33):e2302622.

PMID: 37847907 PMC: 10667797. DOI: 10.1002/advs.202302622.

Investigations into the effects of scaffold microstructure on slow-release system with bioactive factors for bone repair.

Pei B, Hu M, Wu X, Lu D, Zhang S, Zhang L Front Bioeng Biotechnol. 2023; 11:1230682.

PMID: 37781533 PMC: 10537235. DOI: 10.3389/fbioe.2023.1230682.

BMP-6 promotes type 2 immune response during enhancement of rat mandibular bone defect healing.

McColl L, Chen X, Solga M, Schlegel K, Haughey S, Lobo P Front Immunol. 2023; 14:1064238.

PMID: 36845161 PMC: 9950738. DOI: 10.3389/fimmu.2023.1064238.

Human Non-Hypertrophic Nonunion Tissue Contains Osteoblast Lineage Cells and E-BMP-2 Activates Osteogenic and Chondrogenic Differentiation.

Yoshikawa R, Fukui T, Oe K, Kumabe Y, Oda T, Sawauchi K Curr Issues Mol Biol. 2022; 44(11):5562-5578.

PMID: 36354689 PMC: 9688795. DOI: 10.3390/cimb44110377.

References

Wozney J, Rosen V, Celeste A, Mitsock L, Whitters M, Kriz R . Novel regulators of bone formation: molecular clones and activities. Science. 1988; 242(4885):1528-34. DOI: 10.1126/science.3201241. View

Einhorn T, Majeska R, Mohaideen A, Kagel E, Bouxsein M, Turek T . A single percutaneous injection of recombinant human bone morphogenetic protein-2 accelerates fracture repair. J Bone Joint Surg Am. 2003; 85(8):1425-35. DOI: 10.2106/00004623-200308000-00002. View

Govender S, Csimma C, Genant H, Valentin-Opran A, Amit Y, Arbel R . Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am. 2002; 84(12):2123-34. DOI: 10.2106/00004623-200212000-00001. View

Seeherman H, Li R, Bouxsein M, Kim H, Li X, Smith-Adaline E . rhBMP-2/calcium phosphate matrix accelerates osteotomy-site healing in a nonhuman primate model at multiple treatment times and concentrations. J Bone Joint Surg Am. 2006; 88(1):144-60. DOI: 10.2106/JBJS.D.02453. View

Shore E, Xu M, Feldman G, Fenstermacher D, Cho T, Choi I . A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat Genet. 2006; 38(5):525-7. DOI: 10.1038/ng1783. View

Seeherman H, Bouxsein M, Kim H, Li R, Li X, Aiolova M . Recombinant human bone morphogenetic protein-2 delivered in an injectable calcium phosphate paste accelerates osteotomy-site healing in a nonhuman primate model. J Bone Joint Surg Am. 2004; 86(9):1961-72. DOI: 10.2106/00004623-200409000-00015. View

Pecina M, Haspl M, Jelic M, Vukicevic S . Repair of a resistant tibial non-union with a recombinant bone morphogenetic protein-7 (rh-BMP-7). Int Orthop. 2003; 27(5):320-1. PMC: 3461861. DOI: 10.1007/s00264-003-0475-4. View

Khouri R, Koudsi B, Reddi H . Tissue transformation into bone in vivo. A potential practical application. JAMA. 1991; 266(14):1953-5. View

Urist M . Bone: formation by autoinduction. Science. 1965; 150(3698):893-9. DOI: 10.1126/science.150.3698.893. View

10.

Warnke P, Springer I, Wiltfang J, Acil Y, Eufinger H, Wehmoller M . Growth and transplantation of a custom vascularised bone graft in a man. Lancet. 2004; 364(9436):766-70. DOI: 10.1016/S0140-6736(04)16935-3. View

11.

Betz O, Betz V, Nazarian A, Pilapil C, Vrahas M, Bouxsein M . Direct percutaneous gene delivery to enhance healing of segmental bone defects. J Bone Joint Surg Am. 2006; 88(2):355-65. DOI: 10.2106/JBJS.E.00464. View

12.

Finkemeier C . Bone-grafting and bone-graft substitutes. J Bone Joint Surg Am. 2002; 84(3):454-64. DOI: 10.2106/00004623-200203000-00020. View

13.

Pecina M, Giltaij L, Vukicevic S . Orthopaedic applications of osteogenic protein-1 (BMP-7). Int Orthop. 2001; 25(4):203-8. PMC: 3620827. DOI: 10.1007/s002640100262. View

14.

Shafritz A, Shore E, Gannon F, Zasloff M, TAUB R, Muenke M . Overexpression of an osteogenic morphogen in fibrodysplasia ossificans progressiva. N Engl J Med. 1996; 335(8):555-61. DOI: 10.1056/NEJM199608223350804. View

15.

Kenneth Burkus J, Transfeldt E, Kitchel S, Watkins R, Balderston R . Clinical and radiographic outcomes of anterior lumbar interbody fusion using recombinant human bone morphogenetic protein-2. Spine (Phila Pa 1976). 2002; 27(21):2396-408. DOI: 10.1097/00007632-200211010-00015. View

16.

Swiontkowski M, Aro H, Donell S, Esterhai J, Goulet J, Jones A . Recombinant human bone morphogenetic protein-2 in open tibial fractures. A subgroup analysis of data combined from two prospective randomized studies. J Bone Joint Surg Am. 2006; 88(6):1258-65. DOI: 10.2106/JBJS.E.00499. View

17.

Friedlaender G, Perry C, Cole J, Cook S, Cierny G, Muschler G . Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J Bone Joint Surg Am. 2001; 83-A Suppl 1(Pt 2):S151-8. PMC: 1425155. View

18.

Diefenderfer D, Osyczka A, Garino J, Leboy P . Regulation of BMP-induced transcription in cultured human bone marrow stromal cells. J Bone Joint Surg Am. 2003; 85-A Suppl 3:19-28. PMC: 1351076. DOI: 10.2106/00004623-200300003-00005. View

19.

Kloen P, Di Paola M, Borens O, RICHMOND J, Perino G, Helfet D . BMP signaling components are expressed in human fracture callus. Bone. 2003; 33(3):362-71. DOI: 10.1016/s8756-3282(03)00191-1. View